[New approaches for encapsulation of peptides into poly(lactic/glycolic acid) microspheres].
The aim of the work was to develop small microspheres made from a biodegradable polymer, poly(lactide-co-glycolide), in order to entrap small peptides. Microspheres prepared by a water-in-oil-in-water emulsion solvent evaporation technique displayed a mean diameter below than 10 microns and showed high encapsulation efficiency of a 33 amino acid peptide (V3 BRU). In vitro release kinetics studies showed that such microparticles could be employed for both oral immunization and controlled release. The encapsulation of a seven aminoacid peptide in the same conditions, led to a very low encapsulation efficiency. In order to increase the entrapment efficiency, two strategies were adopted: taking into account the solubility of pBC 264 at different pH, a pH gradient was created to prevent the leakage of the encapsulated peptide into the outer aqueous phase. The inner aqueous phase was maintained at basic pH where the peptide was soluble, while the external aqueous phase was acidic: ovalbumin was added during preparation to stabilize the inner emulsion. These two strategies allowed to increase significantly the encapsulation rate of pBC 264. Nevertheless, the in vitro release kinetics of the peptide were strongly influenced by the presence of ovalbumin which seems to form pores in the microsphere structure (80% of the total peptide content was released after 30 minutes). By contrast, when ovalbumin was replaced by Pluronic F 68 microspheres did not have pores, thus the release profile and the extent of the burst were much smaller. When microspheres were stereotactically implanted in the rat brain, in vivo release profiles were in good agreement with the release observed in vitro. In conclusion, these microspheres are well suited for the slow delivery of neuropeptides in the brain, a feature expected to facilitate the study of long term effects of these compounds.
Blanco-Prieto
M J
MJ
Ecole Polytechnique Fédérale de Zürich, ETH IRCHEL, Suisse.
Fattal
E
E
Puisieux
F
F
Couvreur
P
P
D000818:Animals; D002214:Capsules; D019344:Lactic Acid; D008863:Microspheres; D010455:Peptides / Q000008:administration & dosage*; D011100:Polyglycolic Acid; D011108:Polymers; D051381:Rats
D002214:Capsules; D010455:Peptides; D011108:Polymers; D011100:Polyglycolic Acid; D019344:Lactic Acid
Nouvelles approches pour l'encapsulation de peptides au sein de microsphères de PLG.